Vaccine News and Research

Latest Vaccine News and Research

New insights into the driving factors of COVID-19 dynamics in England

In a recent study posted to the medRxiv* preprint server, researchers provided quantitative estimates of population-level drivers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and infection severity by fitting coronavirus disease 2019 (COVID-19) epidemiological surveillance data from England into dynamic transmission models.

15 Feb 2023

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

A study conducted by US-based scientists claims that bivalent mRNA booster vaccines do not have any added benefits over monovalent booster vaccines in terms of inducing robust and durable neutralizing antibody response against omicron subvariants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Feb 2023

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Scientists at The University of Queensland have developed a novel vaccine for Japanese encephalitis virus (JEV) in pigs, to help stop the spread of the disease in Australia.

15 Feb 2023

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.

15 Feb 2023

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

A meta-analysis on the long-term vaccine effectiveness of four COVID-19 vaccines.

14 Feb 2023

New insights into the role of T-cells during long COVID

Researchers characterize the trajectory of long COVID in patients eight months after recovering from infection.

14 Feb 2023

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Researchers assess longitudinal alterations in SARS-CoV-2 IgG antibody titers after vaccination.

13 Feb 2023

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

A recent study examines the neutralization of SARS-CoV-2 Omicron sub-variants by sera from boosted individuals and those with breakthrough infection.

13 Feb 2023

New analytical platform quantifies the structure of mRNA-based medicines

Researchers from Tokyo Metropolitan University and RIKEN CSRS have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA) based medicines.

13 Feb 2023

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination

Researchers examined the factors associated with stroke following coronavirus disease 2019 (COVID-19) vaccination.

13 Feb 2023

The immunogenicity of two leading malaria vaccine candidates delivered as mRNA-LNP vaccines

Researchers evaluated the immunogenicity of two vaccine candidates, Pfs25 and PfCSP, based on the mRNA-lipid nanoparticle (LNP) platform.

13 Feb 2023

Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients

Researchers reported the immune protection conferred by monovalent COVID-19 vaccines and bivalent booster doses.

13 Feb 2023

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

A new study in the journal Clinical Infectious Diseases aimed to determine the relative vaccine effectiveness (rVE) in three different recipient cohorts, those who received the Ad26.COV2.S vaccine followed by Ad26.COV2.S booster, those who received the Ad26.COV2.S vaccine followed by an mRNA booster, and those who received two doses of an mRNA vaccine followed by an mRNA booster.

12 Feb 2023

UQ-led research effort secures almost $8 million to develop an mRNA Strep A vaccine

A University of Queensland-led research effort to develop an mRNA vaccine against Group A Streptococcus (Strep A) has secured almost $8 million in philanthropic funding.

10 Feb 2023

Public health agencies turn to locals to extend reach into immigrant communities

When covid-19 vaccines became available, Colorado public health officials initially relied on mass vaccination events publicized through Facebook, email, and texts, and required Coloradans to book appointments online.

10 Feb 2023

Era of ‘free’ covid vaccines, test kits, and treatments is ending. Who will pay the tab now?

Time is running out for free-to-consumer covid vaccines, at-home test kits, and even some treatments.

10 Feb 2023

Maternal covid-19 vaccination during pregnancy may reduce risk of hospital admission in infants

Two doses of mRNA covid-19 vaccine during pregnancy are highly effective against delta and moderately effective against omicron infection, and are linked to a lower risk of hospital admission in infants under six months of age, finds a Canadian study published by The BMJ today.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Previous
1
...
90
91
92
93
94
95
96
...
1125
Next

Vaccine News and Research

Latest Vaccine News and Research

New insights into the driving factors of COVID-19 dynamics in England

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

New insights into the role of T-cells during long COVID

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

New analytical platform quantifies the structure of mRNA-based medicines

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination

The immunogenicity of two leading malaria vaccine candidates delivered as mRNA-LNP vaccines

Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

UQ-led research effort secures almost $8 million to develop an mRNA Strep A vaccine

Public health agencies turn to locals to extend reach into immigrant communities

Era of ‘free’ covid vaccines, test kits, and treatments is ending. Who will pay the tab now?

Maternal covid-19 vaccination during pregnancy may reduce risk of hospital admission in infants

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in